CDC-NCHSTP-DHAP: HIV/AIDS Surveillance Supplemental Report

Table 8. Estimated numbers of persons living with HIV infection (not AIDS), by race/ethnicity, sex, exposure category, and age category at diagnosis, 1999–2002—30 areas with confidential name-based HIV infection reporting

	Year
Exposure category	1999	2000	2001	2002
Asian/Pacific Islander
Male adult or adolescent
Male-to-male sexual contact	208	249	275	313
Injection drug use	35	44	53	64
Male-to-male sexual contact and injection drug use	14	16	19	20
Heterosexual contact	41	47	55	66
Other^a	4	5	4	5
Subtotal	301	361	405	468

Female adult or adolescent
Injection drug use	19	22	25	25
Heterosexual contact	90	101	116	132
Other^a	2	2	4	5
Subtotal	111	125	145	162

Total adults and adolescents	412	486	551	630

Child (<13 yrs)
Perinatal	7	7	7	9
Other^a	5	5	5	5
Subtotal	12	12	12	14

Total	424	498	563	644

	Year
Exposure category	1999	2000	2001	2002
American Indian/Alaska Native
Male adult or adolescent
Male-to-male sexual contact	319	336	359	373
Injection drug use	87	87	86	86
Male-to-male sexual contact and injection drug use	86	90	84	85
Heterosexual contact	40	46	47	51
Other^a	2	2	2	3
Subtotal	535	562	578	597

Female adult or adolescent
Injection drug use	69	73	74	79
Heterosexual contact	108	120	128	141
Other^a	1	1	1	1
Subtotal	178	193	203	220

Total adults and adolescents	712	755	781	818

Child (<13 yrs)
Perinatal	8	8	8	9
Other^a	3	3	3	3
Subtotal	11	11	11	12

Total	723	766	792	830

Total Cases^b

117,844

126,541

135,141

144,129

Note. These numbers do not represent actual cases in persons living with HIV infection (not AIDS). Rather, these numbers are point estimates of persons living with HIV infection(not AIDS) that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk. The estimates have not been adjusted for incomplete reporting. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.

Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
^a Includes hemophilia, blood transfusion, and risk not reported or not identified.
^b Includes persons of unknown race or multiple races and persons of unknown sex.

Added on: May 5, 2004
Centers for Disease Control & Prevention
National Center for HIV, STD, and TB Prevention
Divisions of HIV/AIDS Prevention
Contact Us